Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.
about
The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approachSentinel lymph node evaluation in women with cervical cancerCumulative sum: a proficiency metric for basic endoscopic training.Attaining proficiency with endobronchial ultrasound-guided transbronchial needle aspiration.Sentinel node biopsy in breast cancer using infrared laser system first experience with PDE cameraThe adaptation process of a teaching and research hospital to changing trends in modern breast surgery.Sentinel lymph node identification by blue dye in patients with breast carcinomaImplementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities.Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.The role of sentinel lymph node mapping in small animal veterinary medicine: A comparison with current approaches in human medicine.A prospective randomized trial comparing patent blue and methylene blue for the detection of the sentinel lymph node in breast cancer patients.Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures.Success and safety of methylene blue as the sole agent for sentinel lymph node identification in early breast cancer.Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysisQuality Indicators for Sentinel Lymph Node Biopsy in Breast Cancer: Applicability and Clinical Relevance in a Non-screened Population
P2860
Q26765937-79463EA4-05F1-44F4-9556-008054F56DDEQ26852144-FE5A4E15-EF25-4C24-82AF-CBD291A7FA59Q30370172-63295728-8291-466B-B5CB-37212D7CC3AFQ30409343-50E93611-F76F-4E26-A496-1E620C539351Q35078658-BD237169-FBBD-493D-9F7D-43D4FAA58688Q35556863-3055834A-F696-4FE8-84CC-D6F9D4F4E206Q36876475-0080C530-B1ED-4C56-85E4-6447CB19F61EQ37832409-82DCA454-4515-4E0F-8712-BA735058D64DQ38213539-D418F4AF-13B6-42E3-A86E-3BC5AF686AEEQ48232164-4D6804D0-8F67-4E3B-BAB8-4BC4EF29518DQ50181812-7805C9C9-3D26-4D0B-8BDF-C3E32DCC3FBEQ50186416-3A56693F-590C-40CC-BD12-5D4B711F0182Q50241634-39E81B55-67BE-415B-ADF3-31E3336416E4Q50245239-F464F2AB-B278-43C8-8774-133E3438AD05Q57105831-D591A4C9-BEE9-4B4E-92EB-38D778685DE2Q57123974-F830F664-8753-47F3-A2B5-40A1AE615D62
P2860
Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@ast
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@en
type
label
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@ast
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@en
prefLabel
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@ast
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@en
P2093
P2860
P356
P1433
P1476
Sentinel lymph node biopsy for ...... mulative sum (CUSUM) analysis.
@en
P2093
Christopher S P Valentine
Emil Kanchev
Garfield O Blake
Jeffrey M East
P2860
P2888
P356
10.1186/1471-2482-9-2
P577
2009-01-27T00:00:00Z
P5875
P6179
1023669136